London’s Institute of Cancer Research has unveiled plans for a new global hub for cancer research and treatment
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
US Patent Office declares ‘interference’ between patents from Doudna and Zhang
2016 to see the launch of new Wellcome Genome Campus innovation centre for genomics and biodata businesses.
We chat with Genomics plc CEO John Colenutt about big data and what they’ll be up to Festival of Genomics
Illumina spin-off Grail aims to develop $1000 or less tests for early cancer diagnosis.
Onramp Bioinformatics are creating use-friendly infrastructure for genomic data. CEO and Founder Tim Wesselman explains how.
Illumina accelerater announces third round of funding for genomics start ups.
This Week in Genomics all eyes have been on Washington for the International Summit on Human Gene Editing.
Check out just some of the opportunities available on the Front Line Genomics Jobs Board this month
Cypher Genomics to bring their interpretation technology to bear on Human Longevity’s extensive genomics database.
The International Cancer Genome Consortium have announced that 1,200 cancer whole genome sequences are now available via Amazon Web Services.
Thermo Fisher Scientific forms long-term partnership with Novartis and Pfizer to develop non-small cell cancer test to serve as companion diagnostic across drug development.